# PIK3CA in HER2+ BC and pCR Trial

> **NCT05750693** · NA · UNKNOWN · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 58 (estimated)

## Conditions studied

- HER2-positive Breast Cancer

## Interventions

- **GENETIC:** PIK3CA analysis

## Key facts

- **NCT ID:** NCT05750693
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-02
- **Primary completion:** 2023-09-01
- **Final completion:** 2023-09-01
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2023-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05750693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05750693, "PIK3CA in HER2+ BC and pCR Trial". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05750693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*